Commercial Information Circulars
24-hour hotline : 23 922 922
e-mail address : enquiry@tid.gov.hk
Ref. : EIC 631/2/5/1
16 May 2017
Dear Sirs,
Commercial Information Circular No. 381/2017
The Mainland of China : Public Consultation on the "Policy Related to Promoting the Innovation and Protection of Rights of New Drugs and Medical Devices' Developers (Consultation Draft)"
The China Food and Drug Administration (CFDA) of the People's Republic of China is currently seeking public comments on the "Policy Related to Promoting the Innovation and Protection of Rights of New Drugs and Medical Devices' Developers (Consultation Draft)". The deadline is 10 June 2017. Please refer to Appendix (pdf format) for the notice (available in Chinese only). Interested parties may send their comments to the CFDA (please refer to the Appendix for details).
ENQUIRIES
2.If you have any questions on the content of the document mentioned in this circular, please contact the issuing authority of the Mainland of China direct. For other questions on this circular, please contact Mainland Branch (I) (tel: 2398 5444) of the Department.
Yours faithfully,
(Ms Helen CHENG)
for Director-General of Trade and Industry
Note: While every effort is made to ensure the accuracy of the above information, the Department cannot guarantee this to be so and will not be held liable for any reliance placed on the same.